Network TodayNetwork Today
    What's Hot

    Border Patrol seized enough fentanyl to kill entire US population this fiscal year

    September 27, 2023

    New COVID poll: Democrats have a ‘particularly negative’ outlook, are most likely to keep wearing masks

    September 27, 2023

    Texas special needs student who doesn’t know how to talk dropped off at wrong school

    September 27, 2023
    Facebook Twitter Instagram
    • About
    • Privacy Policy
    • Terms
    • Contact
    Facebook Twitter Instagram
    Wednesday, September 27
    Network TodayNetwork Today
    • Home
    • News
    • Politics
    • Business
    • Energy
    • Technology
    • Health
    • Lifestyle
    • Sports
    Network TodayNetwork Today
    Home » F.D.A. Panel Rejects Lilly’s Cancer Drug Tested Only in China

    F.D.A. Panel Rejects Lilly’s Cancer Drug Tested Only in China

    February 11, 20222 Mins Read Health
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The agency has long had strict rules about approving drugs that were tested solely overseas, requiring that the data be applicable to patients and medical practice in the United States, that the investigators had “recognized competence” and that the agency be able to validate the data.

    In a withering critique of Lilly’s submission on this new trial from China, F.D.A. staff members assigned to conduct an analysis said that on every count the sintilimab application fell short. One issue was how to evaluate the drug. The study asked how long it took before the cancer started growing again or before the patient died. That endpoint, known as progression free survival, Dr. Pazdur said at the meeting, is out of date for such studies. Instead, the appropriate endpoint, he suggested, is what matters to patients most — how long will they live.

    “There’s a famous story of Avastin in metastatic breast cancer,” Dr. Berry said. “It showed enormous benefit for progression-free survival, but with additional follow-up it was not beneficial for overall survival.”

    A few years ago, progression-free survival might have been more acceptable but, Dr. Pazdur said, it no longer is and it’s another example of how “the landscape has changed.”To get Lilly’s drug approved, the panel voted to recommend requiring another trial that would be applicable to U.S. patients.

    But Dr. Jorge Nieva, associate professor of medicine at the University of Southern California, who was the only dissenting panel member, said there was no evidence that the data was unreliable and that it was not the panel’s job to determine how many drugs on the market would be too many.

    “Having more drugs competing for those same patients will have, I think, greater impact on equity than the need for diversity in clinical trial enrollment, which I believe is important,” Dr. Nieva said.

    But Dr. Pazdur’s views carried the day, alluding to more policy changes, perhaps.

    “There is a change in our perception of what we want from international trials,” he said. China has, so far, rarely participated.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    New COVID poll: Democrats have a ‘particularly negative’ outlook, are most likely to keep wearing masks

    September 27, 2023

    How Much Coffee Is Too Much Coffee?

    September 26, 2023

    Depression risk spikes for those who eat these unhealthy foods, study finds: ‘Not a coincidence’

    September 26, 2023

    Dating After 60: A Lot of Roses, Some Thorns

    September 26, 2023

    Dengue fever: What you need to know about the mosquito-borne illness sweeping Jamaica

    September 25, 2023

    Bruce Willis’ FTD battle: Expert shares warning signs, what to know about the condition

    September 25, 2023
    Trending

    Border Patrol seized enough fentanyl to kill entire US population this fiscal year

    September 27, 2023

    New COVID poll: Democrats have a ‘particularly negative’ outlook, are most likely to keep wearing masks

    September 27, 2023

    Texas special needs student who doesn’t know how to talk dropped off at wrong school

    September 27, 2023

    Greek government to address acute labor shortages as country faces surge of illegal migrants

    September 27, 2023
    Latest News

    A Swiss-Korean French Tutor Grapples With the Boundaries of Language

    October 22, 2022

    Oprah doesn’t want Dianne Feinstein’s Senate seat, spokesperson says

    May 26, 2023

    To Understand New Extremism, Look to History

    November 7, 2022

    On the Quiet Hardcourts in Spain, Carlos Alcaraz’s Star Was Already Shining

    September 12, 2022

    Monday’s earthquake was as powerful as the strongest recorded in Turkey in 1939.

    February 6, 2023

    King Charles III reportedly considered changing his regnal name to distance himself from Charles I & II

    September 9, 2022

    Network Today is one of the biggest English news portal, we provide the latest news from all around the world.

    We're social. Connect with us:

    Facebook Twitter Instagram Pinterest YouTube
    Recent

    Border Patrol seized enough fentanyl to kill entire US population this fiscal year

    September 27, 2023

    New COVID poll: Democrats have a ‘particularly negative’ outlook, are most likely to keep wearing masks

    September 27, 2023

    Texas special needs student who doesn’t know how to talk dropped off at wrong school

    September 27, 2023
    Featured

    Indiana residents fight back, take down would-be robber in apartment break-in, police say

    October 29, 2022

    Ohio boy, 6, severely burned saving brother from burning car

    October 9, 2022

    House fire in North Carolina’s Outer Banks kills three vacationers

    August 12, 2023
    Copyright ©️ All rights reserved | Network Today
    • About
    • Privacy Policy
    • Terms
    • Contact

    Type above and press Enter to search. Press Esc to cancel.